ClearPoint Neuro Inc (CLPT)
6.195
-0.20
(-3.20%)
USD |
NASDAQ |
May 17, 16:00
6.195
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Research and Development Expense (Quarterly): 2.625M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.625M |
| December 31, 2023 | 2.652M |
| September 30, 2023 | 2.429M |
| June 30, 2023 | 3.605M |
| March 31, 2023 | 3.023M |
| December 31, 2022 | 2.927M |
| September 30, 2022 | 2.654M |
| June 30, 2022 | 2.411M |
| March 31, 2022 | 2.901M |
| December 31, 2021 | 3.073M |
| September 30, 2021 | 2.601M |
| June 30, 2021 | 2.109M |
| March 31, 2021 | 1.563M |
| December 31, 2020 | 1.912M |
| September 30, 2020 | 1.143M |
| June 30, 2020 | 0.812M |
| March 31, 2020 | 0.818M |
| December 31, 2019 | 0.7658M |
| September 30, 2019 | 0.7619M |
| June 30, 2019 | 0.6978M |
| March 31, 2019 | 0.5845M |
| December 31, 2018 | 0.4813M |
| September 30, 2018 | 0.6172M |
| June 30, 2018 | 0.6653M |
| March 31, 2018 | 0.5463M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.5821M |
| September 30, 2017 | 0.5897M |
| June 30, 2017 | 1.084M |
| March 31, 2017 | 0.5577M |
| December 31, 2016 | 0.5297M |
| September 30, 2016 | 0.6913M |
| June 30, 2016 | 0.7499M |
| March 31, 2016 | 0.6572M |
| December 31, 2015 | 0.5226M |
| September 30, 2015 | 0.4803M |
| June 30, 2015 | 0.4269M |
| March 31, 2015 | 0.5275M |
| December 31, 2014 | 0.7077M |
| September 30, 2014 | 0.8734M |
| June 30, 2014 | 0.8984M |
| March 31, 2014 | 0.8176M |
| December 31, 2013 | 0.6843M |
| September 30, 2013 | 0.7253M |
| June 30, 2013 | 0.7418M |
| March 31, 2013 | 0.7715M |
| December 31, 2012 | 0.7352M |
| September 30, 2012 | 0.5736M |
| June 30, 2012 | -0.3965M |
| March 31, 2012 | 0.6897M |
| December 31, 2011 | 1.118M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.6978M
Minimum
Jun 2019
3.605M
Maximum
Jun 2023
2.074M
Average
2.42M
Median
Research and Development Expense (Quarterly) Benchmarks
| icad Inc | 1.507M |
| Perspective Therapeutics Inc | 7.452M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |